Angsuman Chakraborty01 Jan 2006 12:47 pm
A course of hyperbaric oxygen treatment was found to increase by eight-fold the number of stem cells circulating in a patient’s body according to a study to be published in the American Journal of Physiology-Heart and Circulation Physiology.
“This is the safest way clinically to increase stem cell circulation, far safer than any of the pharmaceutical options,” said Stephen Thom, MD, Ph.D., Professor of Emergency Medicine at the University of Pennsylvania School of Medicine and lead author of the study. “This study provides information on the fundamental mechanisms for hyperbaric oxygen and offers a new theoretical therapeutic option for mobilizing stem cells.”
“We reproduced the observations from humans in animals in order to identify the mechanism for the hyperbaric oxygen effect,” added Thom. “We found that hyperbaric oxygen mobilizes stem/progenitor cells because it increases synthesis of a molecule called nitric oxide in the bone marrow. This synthesis is thought to trigger enzymes that mediate stem/progenitor cell release.”
via ScienceDaily [www.sciencedaily.com]
Filed under Stem Cell | 1 Comment
Related?
Hyperbaric Oxygen Therapy to stimulate stem cell formationFebruary 23rd, 2009 HBOT involves breathing pure oxygen to higher than atmospheric pressures in an enclosed chamber This treatment is used to treat divers who suffer from bends or decompression sickness. The experts of Edinburgh University will conduct a clinical trial to study whether HBOT can improve liver functions and stimulate bone marrow stem cells.
Stem cell trials on Diabetic patient shows new hopeMarch 30th, 2009 Recent adult stem cell trials (phase I) on type 2 diabetic patients are showing encouraging results. The new treatment shows the ability to produce natural insulin inside the body and thus really offers positive hope to the 24 millions of Americans who are suffering from the killer disease.
Stem cell treatment is the only hope for born blind British childApril 30th, 2009 He is Joshua Clark, only 22 months old suffering from Optic Nerve Hypoplasia, an untreatable eye condition that put him into the world of darkness. After raising £40,000 through sponsored bike rides, charity auctions and hundreds of small donations from members of the public, the family is due to arrive in China on Thursday to begin the treatment at a specialist hospital in the city of Hangzhou, two hours from Shanghai.
Stem cell derived from adipose tissue will be used in chronic heart disease trialMay 27th, 2009 Regenerative medicine technology company Cytori is all set to investigate adipose derived stem cells and regenerative cells in the trial of chronic heart disease. The trial was carried out at leading cardiology centers in Europeis named as PRECISE study, It enrolled 27 patients (the protocol allowed for up to 36 patients) patients who were specifically suffering from an advanced form of chronic heart disease, known as chronic myocardial ischemia, for which there is no generally accepted treatment.
Menstrual blood cells can cure incurable diseaseAugust 21st, 2008 Latest research done by the researchers of Indiana University reveals that stem cells obtained from Menstrual blood can successfully restore the limbs of the patients suffering from Critical Limb Ischemia. This research was done by Dr.
Bone Marrow Stem Cells Treatment Recovered Acute Heart Attack PatientsOctober 23rd, 2006 Patients who recently have suffered an acute heart attack are being recruited for a new Emory University School of Medicine clinical study using stem cells generated within the bone marrow to grow new blood vessels to improve circulation around the heart and enhance its function. Although many patients recover at least partially from heart attacks, approximately 70 percent suffer permanent damage because the artery blockage causing the attack keeps oxygen from reaching parts of the heart muscle.
Stem cell nutritional supplement-StemEnhance producer Stem Cell Nutrition Company is in the final for prestigious DSA AwardJune 4th, 2009 Stem cell nutritional supplement-StemEnhance producer Stem Cell Nutrition Company is in the final for prestigious DSA Rising Star Award
According to an announcement form STEMTech HealthSciences Inc., it has been chosen from among approximately 500 Direct Selling Association (DSA) member companies as one of the three finalists for the prestigious DSA Rising Star award. STEMTech is responsible for bringing to market the world's first and only scientifically proven stem cell nutritional supplement, StemEnhance(R).
Researchers find another hope for stem cell use in heart diseaseNovember 4th, 2008 It can be called a major step towards the use of stem cell therapies for heart disease. The researchers in the University of Bristol, found that our bodies' ability to respond to an internal 'mayday' signal may hold the key to success for long-awaited regenerative medicine.
One Response
Leave a Comment
August 21st, 2008 at 7:28 pm
que bobada no se entiende nada